Spatiotemporal temperature distribution and cancer cell death in response to extracellular hyperthermia induced by gold nanorods.
Plasmonic nanoparticles have shown promise in hyperthermic cancer therapy, both in vitro and in vivo. Previous reports have described hyperthermic ablation using targeted and nontargeted nanoparticles internalized by cancer cells, but most reports do not describe a theoretical analysis for determining optimal parameters. The focus of the current research was first to evaluate the spatiotemporal temperature distribution and cell death induced by extracellular hyperthermia in which gold nanorods (GNRs) were maintained in the dispersion outside human prostate cancer cells. The nanorod dispersion was irradiated with near-infrared (NIR) laser, and the spatiotemporal distribution of temperature was determined experimentally. This information was employed to develop and validate theoretical models of spatiotemporal temperature profiles for gold nanorod dispersions undergoing laser irradiation and the impact of the resulting heat generation on the viability of human prostate cancer cells. A cell injury/death model was then coupled to the heat transfer model to predict spatial and temporal variations in cell death and injury. The model predictions agreed well with experimental measurements of both temperature and cell death profiles. Finally, the model was extended to examine the impact of selective binding of gold nanorods to cancer cells compared to nonmalignant cells, coupled with a small change in cell injury activation energy. The impact of these relatively minor changes results in a dramatic change in the overall cell death rate. Taken together, extracellular hyperthermia using gold nanorods is a promising strategy, and tailoring the cellular binding efficacy of nanorods can result in varying therapeutic efficacies using this approach.
Huang
Huang-Chiao
HC
Chemical Engineering, Arizona State University, Tempe, Arizona 85287-6106, USA.
Rege
Kaushal
K
Heys
Jeffrey J
JJ
D016923:Cell Death / Q000187:drug effects / Q000528:radiation effects; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D005110:Extracellular Space / Q000187:drug effects* / Q000378:metabolism; D006046:Gold / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D006979:Hyperthermia, Induced; D007834:Lasers; D008297:Male; D008954:Models, Biological; D043942:Nanotubes / Q000737:chemistry*; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000628:therapy*; D013696:Temperature; D013997:Time Factors
D006046:Gold
Lasers Surg Med. 2008 Nov;40(9):660-5
18951423
Chemistry. 2008;14(33):10244-50
18850613
Int J Hyperthermia. 2004 Feb;20(1):73-92
14612315
Nanomedicine (Lond). 2007 Oct;2(5):681-93
17976030
Small. 2008 Sep;4(9):1287-92
18686276
Int J Hyperthermia. 2003 May-Jun;19(3):252-66
12745971
Cancer. 1977 Jun;39(6):2637-46
872062
Anal Chem. 2007 Jan 15;79(2):572-9
17222022
Arch Pathol (Chic). 1947 May;43(5):489-502
20243514
Int J Hyperthermia. 2004 Jun;20(4):421-39
15204522
Gene Ther. 2003 Oct;10(22):1882-90
14502217
ACS Nano. 2008 Nov 25;2(11):2213-8
19206385
Cancer J. 2002 May-Jun;8 Suppl 1:S100-12
12075696
Int J Hyperthermia. 2002 May-Jun;18(3):194-202
12028637
Nanomedicine (Lond). 2008 Dec;3(6):777-86
19025452
Nano Lett. 2005 Feb;5(2):301-4
15794615
ACS Nano. 2009 Sep 22;3(9):2686-96
19711944
Invest Radiol. 1997 Nov;32(11):705-12
9387059
Langmuir. 2006 Jan 3;22(1):300-5
16378435
J Natl Cancer Inst. 2006 Mar 1;98(5):335-44
16507830
Biotechnol Bioeng. 2008 Oct 1;101(2):388-99
18500767
Ann Biomed Eng. 2009 Apr;37(4):763-82
19148754
Nat Mater. 2003 Oct;2(10):668-71
12970757
Am J Gastroenterol. 1999 Feb;94(2):322-7
10022623
Nano Lett. 2005 May;5(5):829-34
15884879
Radiology. 2000 Dec;217(3):633-46
11110923
Int J Pharm. 2008 Nov 19;364(1):94-101
18723087
Adv Mater. 2007 Oct 17;19(20):3177-3184
18648528
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9138-43
12886020
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):149-68
11259838
Ann Biomed Eng. 2004 Oct;32(10):1384-98
15535056
Int J Radiat Oncol Biol Phys. 1989 Mar;16(3):535-49
2646256
J Am Chem Soc. 2006 Feb 15;128(6):2115-20
16464114
Cancer Lett. 2008 Sep 28;269(1):57-66
18541363
Int J Hyperthermia. 2008 Jun;24(4):337-45
18465418
Neoplasia. 1999 Jun;1(2):123-7
10933046
Nano Lett. 2007 Apr;7(4):941-5
17335272
ACS Nano. 2009 Oct 27;3(10):2941-52
19856978
Small. 2007 Jul;3(7):1245-52
17523182
J Phys Chem B. 2006 Oct 5;110(39):19220-5
17004772
Anal Chem. 2008 Feb 1;80(3):567-72
18166023
Bioconjug Chem. 2002 Jan-Feb;13(1):3-6
11792172
J Biomech Eng. 2009 Jul;131(7):074507
19640143
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1307-15
18555555
Bioconjug Chem. 2009 Jan;20(1):138-46
19072538
Small. 2008 Oct;4(10):1651-5
18819130
Nano Lett. 2007 Jun;7(6):1591-7
17474783
Leuk Lymphoma. 2003 Nov;44(11):1957-62
14738150
Langmuir. 2008 Dec 16;24(24):14139-44
19360961
Lab Chip. 2008 Mar;8(3):415-9
18305859
J Phys Chem B. 2005 Nov 3;109(43):20331-8
16853630
Phys Rev Lett. 2005 Jan 21;94(2):025901
15698196
Nano Lett. 2005 Jul;5(7):1371-7
16178241
Lasers Surg Med. 2007 Oct;39(9):731-46
17960756
J Appl Physiol. 1948 Aug;1(2):93-122
18887578
Photochem Photobiol. 2006 Mar-Apr;82(2):412-7
16613493